Literature DB >> 8023952

Characterization of muscarinic receptor subtypes in pig airways: radioligand binding and northern blotting studies.

E B Haddad1, J C Mak, A Hislop, S G Haworth, P J Barnes.   

Abstract

This study was undertaken to characterize the muscarinic receptor subtypes present in adult pig peripheral lung and airway smooth muscle. The binding of the nonselective muscarinic antagonist [N-methyl-3H]scopolamine ([3H]NMS) to pig airways showed a single class of binding sites with a maximum density of 172 and 450 fmol/mg protein in peripheral lung and airway smooth muscle, respectively. Unlike [3H]NMS, the M1-selective antagonist, [3H]telenzepine, recognized two populations of binding sites in peripheral lung. Approximately 14% of total [3H]telenzepine binding sites displayed high affinity [dissociation constant (Kd) = 0.95 nM], whereas the remaining sites showed low affinity (Kd = 14.2 nM). The high- and the low-affinity [3H]telenzepine binding sites displayed the pharmacological profile of M1 and M2 receptors, respectively. Heterogeneity of pig airways muscarinic receptor was also revealed by competitive binding experiments against [3H]NMS with the M2-selective antagonist methoctramine. This compound recognized 70 and 90% of total receptors with high affinity in airway smooth muscle (Ki = 4.44 nM) and peripheral lung (Ki = 9.82 nM), respectively. This result suggests that the dominant muscarinic receptor in pig airways is of the M2 subtype. Northern blot analysis demonstrated the presence of m1 and m2 mRNAs transcripts in peripheral lung and m2 and m3 mRNAs in airway smooth muscle with no evidence for m4 mRNA.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8023952     DOI: 10.1152/ajplung.1994.266.6.L642

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  9 in total

Review 1.  G Protein-Coupled Receptors in Asthma Therapy: Pharmacology and Drug Action.

Authors:  Stacy Gelhaus Wendell; Hao Fan; Cheng Zhang
Journal:  Pharmacol Rev       Date:  2020-01       Impact factor: 25.468

2.  Segment-dependent expression of muscarinic acetylcholine receptors and G-protein coupling in the equine respiratory tract.

Authors:  G Abraham; C Kottke; H Ammer; S Dhein; F R Ungemach
Journal:  Vet Res Commun       Date:  2006-12-15       Impact factor: 2.459

3.  Pharmacological characterization of the muscarinic receptor antagonist, glycopyrrolate, in human and guinea-pig airways.

Authors:  E B Haddad; H Patel; J E Keeling; M H Yacoub; P J Barnes; M G Belvisi
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

4.  On muscarinic control of neurogenic mucus secretion in ferret trachea.

Authors:  S I Ramnarine; E B Haddad; A M Khawaja; J C Mak; D F Rogers
Journal:  J Physiol       Date:  1996-07-15       Impact factor: 5.182

5.  M2 muscarinic receptors induce airway smooth muscle activation via a dual, Gbetagamma-mediated inhibition of large conductance Ca2+-activated K+ channel activity.

Authors:  Xiao-Bo Zhou; Iris Wulfsen; Susanne Lutz; Emine Utku; Ulrike Sausbier; Peter Ruth; Thomas Wieland; Michael Korth
Journal:  J Biol Chem       Date:  2008-06-04       Impact factor: 5.157

6.  Isolated porcine bronchi provide a reliable model for development of bronchodilator anti-muscarinic agents for human use.

Authors:  G D'Agostino; A M Condino; L Gioglio; F Zonta; M Tonini; A Barbieri
Journal:  Br J Pharmacol       Date:  2008-06-02       Impact factor: 8.739

7.  Antitussive, expectorant and analgesic effects of the ethanol seed extract of Picralima nitida (Stapf) Th. & H. Durand.

Authors:  Gabriel Dapaah; George Asumeng Koffuor; Priscilla Kolibea Mante; Inemesit Okon Ben
Journal:  Res Pharm Sci       Date:  2016 Mar-Apr

Review 8.  Social Isolation: How Can the Effects on the Cholinergic System Be Isolated?

Authors:  Jaromir Myslivecek
Journal:  Front Pharmacol       Date:  2021-11-30       Impact factor: 5.810

9.  Contribution of Postjunctional M2 Muscarinic Receptors to Cholinergic Nerve-Mediated Contractions of Murine Airway Smooth Muscle.

Authors:  Tuleen Alkawadri; Lorcan P McGarvey; N D Mullins; Mark A Hollywood; Keith D Thornbury; Gerard P Sergeant
Journal:  Function (Oxf)       Date:  2021-10-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.